Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
264 Leser
Artikel bewerten:
(1)

Cataract Surgery Devices Market Outlook, Future Growth Prospects, Competitive, and Regional Analysis | DelveInsight

- The increasing demand for the Cataract Surgery Device Market is because of an increase in cataract disorders prevalence, technical developments in ophthalmic products and an increasing geriatric population

LAS VEGAS, April 22, 2021 /PRNewswire/ -- DelveInsight's 'Cataract Surgery Devices Market, Competitive Landscape and Market Forecast till 2026' report delivers an overview of Cataract Surgery Devices and the historical and forecasted Cataract Surgery Devices market trends in seven major markets namely the United States, Europe [Germany, France, Italy, Spain, the United Kingdom], and Japan. The Cataract Surgery Devices Competitive report also proffers an analysis of the market drivers, market barriers, and unmet medical needs along with a PEST analysis of the market.

DelveInsight Logo

Some of the vital key points of the Cataract Surgery Devices Market Research Report

  • The major companies active in the Cataract Surgery Devices market include Johnson & Johnson, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International Inc., Ziemer Ophthalmic Systems AG, and many others.
  • The very first trifocal lens for cataract surgery patients has been approved by the FDA. The AcrySof IQ PanOptix Trifocal Intraocular lens (IOL) is now available to cataract patients in the United States for the first time.
  • Recently, many femtosecond lasers have been approved by the FDA for being used in cataract surgery performed in the United States.
  • DelveInsight anticipates a higher Cataract Surgery Devices Market share of the United States as compared to other countries.
  • The Cataract Surgery Devices market demand is propelled by an increase in cataract disorders prevalence, technical developments in ophthalmic products, and an increasing geriatric population. However, the high costs associated with cataract surgery, especially in developing economies, are limiting the Cataract Surgery Devices market growth.

For additional insights, visit: Cataract Surgery Devices Competitive Landscape

Cataract Surgery Overview

Cataract Surgery is a procedure that involves the removal of the lens from the eye, and in most scenarios, the lens is replaced with an artificial lens. This surgery is performed for cataract treatment.

Cataract surgery often involves using a high-frequency ultrasound device that causes the breaking of the lens into various small pieces, which are then gently removed from the eye area using suction force. The procedure is also known as phacoemulsification and can be performed with smaller incisions, ensuring faster healing. After removing all the remnants from the eye area, the cataract surgeon inserts an intraocular lens placing it safely behind the iris and pupil, at the exact location where the natural lens was placed.

Cataract Surgery Devices by Product Type

The Cataract Surgery Devices are segmented according to the Product Type-

  • Intraocular Lens (IOL)
  • Ophthalmic Viscoelastic Device (OVD)
  • Phacoemulsification Equipment
  • Femtosecond Laser Equipment.

Intraocular Lens (IOL)

An intraocular lens implant is an artificial replacement for the natural lens of your eye. It is a significant part of the surgery that can be used in fixing cataracts. An intraocular lens, also known as the intraocular implant, is made of clear plastic. There are multiple types of Intraocular lenses- Monofocal IOL, Multifocal implant, and Accommodating IOL.

Ophthalmic Viscoelastic Device (OVD)

Ophthalmic Viscological Devices are gel-like, transparent substances that carry viscous and elastic properties. They are used extensively in modern intraocular procedures and used routinely in cataract surgeries for protecting delicate ocular structures and provide a faster surgery with better visual recovery for the patients. Apart from the various viscoelastic substances, sodium hyaluronate is the most commonly used biopolymer used in Ophthalmic Viscoelastic Devices for intraocular surgery. Albomed introduced their latest innovation in the field of sodium hyaluronate OVDs named Pe-Ha-Blue PLUS, which combines the viscoelastic properties of Pe-Ha-Luron F with trypan blue.

The Cataract Surgery Devices are segmented according to the surgery types-

  • Phacoemulsification
  • Extracapsular Cataract Extraction (Ecce) Surgery
  • Femtosecond Laser Surgery

The Cataract Surgery Devices Market is segmented as End User into-

  • Hospitals
  • Ophthalmology clinics
  • Ambulatory surgical centres

Cataract Surgery Devices Competitive Assessment

Competitive Assessment of Cataract Surgery Devices by Product Type (Illustrative)

S.No.

Company

Product Type

Intraocular Lens

(IOL)

Ophthalmic Viscoelastic Device (OVD)

Phacoemulsification Equipment

Femtosecond Laser Equipment

1

Johnson & Johnson

Yes

Yes

Yes

Yes

2

Novartis AG

Yes

-

Yes

Yes

3

Carl Zeiss Meditec AG

Yes

-

Yes

Yes

4

Essilor International S.A

-

Yes

Yes

Yes

5

HAAG-Streit Holding AG

Yes

Yes

-

Yes

6

Ziemer Ophthalmic

Systems AG

Yes

Yes

-

-

7

Nidek Co., Ltd.

-

Yes

Yes

-

8

Topcon Corporation

-

Yes

-

Yes

9

Valeant

Pharmaceuticals

International, Inc

-

-

Yes

-

Cataract Surgery Devices Product Portfolio

  • TECNIS Multifocal Intraocular Lenses, (+3.25 D)

TECNIS Multifocal Intraocular Lenses, (+3.25 D): The TECNIS Multifocal 1-Piece intraocular lenses, (+3.25 D), are designated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in whom a cataractous lens has been eliminated by phacoemulsification and who need near, intermediate, and distance vision with increased spectacle independence. The TECNIS Multifocal Family of 1-Piece IOLs presents the only multifocal lenses capable of proffering a complete range of high-quality vision (20/25 or better),1,2 customised for each patient's lifestyle.

The TECNIS Multifocal 1-Piece intraocular lenses (+3.25 D) offer cataract patients with options to have a complete range of near, intermediate, and distant vision, with a treatment customised to fulfil their personal requirements and lifestyle. The +3.25 D IOL is ideal for people performing longer reading distances, such as reading a hand-held device.

For more Product Portfolios Along with Company Profiles, visit: Cataract Surgery Devices Competitive Analysis

Scope of the Cataract Surgery Devices Market Insight Report

  • Geography Covered: The United States, Europe [Germany, France, Italy, Spain, the United Kingdom,], and Japan.
  • Study Period: 3-year historical and 8-year forecasted analysis (2018-2026).
  • Cataract Surgery Devices Markets Segmentation: By Geographies, By Product Type, By Surgery Type
  • Dominant Market Companies investigating its candidates for Cataract Surgery Devices: Johnson & Johnson, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International Inc., Ziemer Ophthalmic Systems AG, and several others.
  • Analysis: Comparative and conjoint analysis.
  • Case Studies
  • KOL's Views
  • PEST Analysis

Request for a Webex demo of the report @ Cataract Surgery Devices Market Analysis

Table of Contents

1

Cataract Surgery Devices Key Insights

2

Cataract Surgery Devices Executive Summary

3

Cataract Surgery Devices Background and Overview

4

Cataract Surgery Devices Regulatory Framework

5

Cataract Surgery Devices Reimbursement Scenario

6

Cataract Surgery Devices Company Profiles

6.1

Johnson & Johnson

6.2

Novartis AG

6.3

Carl Zeiss Meditec AG

6.4

Essilor International S.A

6.5

HAAG-Streit Holding AG

6.6

Ziemer Ophthalmic Systems AG

6.7

Nidek Co., Ltd.

6.8

Topcon Corporation

6.9

Valeant Pharmaceuticals International, Inc.

7

Cataract Surgery Devices Competitive Analysis of Listed Products

8

Cataract Surgery Devices KOL Views

9

Cataract Surgery Devices Market Analysis by 7MM

9.1

Market Analysis Globally

9.2

North America Market Analysis

9.3

Europe Market Analysis

9.4

Asia-Pacific Market Analysis

10

Cataract Surgery Devices Market Analysis by Country

10.1.1

Market Size of the United States

10.2

Europe Cataract Surgery Devices Market Analysis

10.2.1

Market Size of Germany

10.2.2

Market Size of France

10.2.3

Market Size of Italy

10.2.4

Market Size of Spain

10.2.5

Market Size of the United Kingdom

10.3.1

Market Size of Japan

11

Cataract Surgery Devices Market Drivers and Barriers

12

Cataract Surgery Devices PEST Analysis

13

Cataract Surgery Devices Unmet Needs

14

Appendix

15

DelveInsight Capabilities

16

Disclaimer

17

About DelveInsight

Browse full report with detailed TOC with charts, figures, tables @ Cataract Surgery Devices Market Report

View Related Reports

  • Cataract Surgery Complications Epidemiology Forecast

DelveInsight's Cataract Surgery Complications Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Cataract Surgery Complications.

  • Hypertrophic Scar Market

DelveInsight's Hypertrophic Scar - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of the disease.

  • Cataract Surgery Complications Pipeline

Cataract Surgery Complications Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cataract Surgery Complications market.

  • Myc Proto-Oncogene Protein Pipeline

Myc Proto-Oncogene Protein Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario.

  • Hepatic Impairment Market

DelveInsight's Hepatic Impairment- Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview and in-depth understanding of Hepatic Impairment.

  • Pertussis Market

DelveInsight's Pertussis - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of the Pertussis Market.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us:

Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.